on ADOCIA (EPA:ADOC)
Adocia announces its participation in key conferences in 2025
Lyon-based biopharmaceutical company Adocia, which specializes in therapeutic solutions for diabetes and obesity, has unveiled its schedule for participation in several investor events in 2025. Among them, the Annual BioPharma Obesity Innovation Forum in San Francisco on January 11, and the renowned JPM 2025 – 43rd Annual Healthcare Meeting, also in San Francisco, from January 13 to 16. Olivier Soula, CEO of Adocia, will speak on the topic of obesity at these conferences.
In Europe, Adocia will be present in Paris at the BioMed Forum on February 4 and Investor Access on April 1 and 2, as well as at the LSX World Congress in London at the end of April. These strategic meetings should strengthen ties with investors and industry players.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ADOCIA news